Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano 9 - 10 aprile 2010 CRT: vi.

Slides:



Advertisements
Similar presentations
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 ICD data.
Advertisements

Presenter Disclosure Information
Cardiac Resynchronization Heart Failure Study Cardiac Resynchronization Heart Failure Study Presented at American College of Cardiology Scientific Sessions.
Advanced Heart Failure: My Approach
Perioperative Management of Heart Failure Gamal Fouad S Zaki, MD Professor of Anesthesiology Ain Shams University
Natale MARRAZZO Francesco SOLIMENE Quando la CRT-P può bastare?
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
La stratificazione del rischio aritmico oltre la frazione di eiezione Milano 17 Aprile 2009 Prof. Luigi Padeletti Heart Failure & Co.
Update on Indications for Cardiac Resynchronization Therapy Maria Rosa Costanzo, M.D., F.A.C.C., F.A.H.A. Medical Director, Midwest Heart Specialists-Advocate.
Maria Rosa Costanzo, M.D., F.A.C.C., F.A.H.A. Medical Director, Midwest Heart Specialists-Advocate Medical Group Heart Failure and Pulmonary Arterial Hypertension.
Left Ventricular Hypertrophy Detection, significance and treatment.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
La selezione dei pazienti candidati alla Terapia Resincronizzante Cardiaca M Cristina Porciani Firenze “Incontri Pitagorici di Cardiologia 2010” “Πυθαγόρειοι.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Renal function and clinical outcomes of patients undergoing ICD and CRTD implantation- Data from the Israeli ICD Registry Alon Eisen, Mahmoud Souleiman,
May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,
Cardiac Resynchronization Therapy (CRT) Is an Effective Treatment for Heart Failure and Indications Are Expanding Multiple trials have shown the clinical.
S. HUNT Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
RALES: Randomized Aldactone Evaluation Study Purpose To determine whether the aldosterone antagonist spironolactone reduces mortality in patients with.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE MORTALITY STATISTICS.
M. JESSUP Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010.
BEST: Beta-blocker Evaluation Survival Trial Purpose To determine whether the β-blocker bucindolol reduces morbidity and mortality in patients with advanced.
CIBIS II Cardiac Insufficiency Bisoprolol Study
COMET: Carvedilol Or Metoprolol European Trial Purpose To compare the effects of carvedilol (a β 1 -, β 2 - and α 1 -receptor blocker) and short-acting.
Natural History of Heart Failure
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients with Heart Failure with preserved Ejection Fraction Effect of Spironolactone.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effect of Intermittent Atrial Tachyarrhythmia.
RCTs in Cardiac Resynchronization Therapy StudyPtNYHALVEFLVEDDRhythmQRSICD PATH-CHF41III,IV≤35%AnySR≥120N MUSTIC58III≤35%≥60SR≥150N MIRACLE453III,IV≤35%≥55SR≥130N.
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Uncertain Value of Renal Artery Interventions:
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Date of download: 11/11/2016 Copyright © The American College of Cardiology. All rights reserved. From: Targeted Left Ventricular Lead Placement to Guide.
– р<0.05 between baseline
Revascularization in Patients With Left Ventricular Dysfunction:
Tyumen Cardiology Center, Russia Tyumen
The 28th Great Wall International Congress of Cardiology
Kuznetsov VA, Soldatova AM, Krinochkin DV, Enina TN
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
2) Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114
The following slides highlight a presentation at the Late-Breaking Clinical Trials session of the American Heart Association Scientific Sessions, November.
Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection  Derek V. Exner, MD, MPH, David.
Cardiac transplant or rotary blood pump: Contemporary evidence
A. Heart failure: A challenge to the healthcare delivery system
INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.
Volume 9, Issue 8, Pages S3-S13 (August 2012)
CIBIS II: Cardiac Insufficiency Bisoprolol Study II
Johannes Steiner et al. JACC 2017;70:
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;3:
Mahesh Anantha Narayanan et al. JACEP 2017;3:
Baseline Characteristics
Angelo Auricchio, and Frits W. Prinzen JACEP 2017;j.jacep
Emilce Trucco et al. JACEP 2018;j.jacep
Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep
Rick A. Nishimura et al. JACC 2017;70:
A. Procopi, N. Procopi, JP Collet, O. Barthelemy, P. Leprince, R
Presentation transcript:

Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 CRT: vi è un vantaggio maggiore nelle donne? M.Cristina Porciani FIRENZE

Heart Failure affects 5.3 millions Americans Nearly 50% of these are women Heart failure contributes 35% of the total female cardiovascular disease mortality Despite this fact, HF in women remains a poorly recognized syndrome and has not received the same public awareness as coronary artery disease

Where Are All the Women With Heart Failure? Lindenfeld J JACC 1997

Prevalence rates of congestive heart failure (CHF) among Framingham Heart Study subjects, by gender and age

Alaeddini J PACE 2008 Prevalence and Mortality from Congestive Herat Failure During years 2004 and 2005 based on Medicare Database

Alaeddini J PACE 2008 Patients who were admitted with diagnosis of congestive heart failure for the years 2002 to 2004 based on Medicare Database

CRT has become a significant part of the management of patients with HF Several large-scale studies demonstrated significant improvement in multiple endpoints, including quality of life, hospitalization rate and survival in patients with advanced HF CRT

Alaeddini J. PACE 2008 Gender Disparity in the Use of CRT in the United States Females underwent CRT-PM or CRT-D implantation % 26% 27%

What is the response to CRT in women ? ► Analysis of previous large CRT Trials ► Few studies addressing this issue

The Multicenter InSync Randomized Clinical Evaluation (MIRACLE) was a prospective, randomized, double-blinded study A total of 453 pts ( 32%women) randomized to either CRT or a control group. MIRACLE study

EFFECT OF CRT ON EFFICACY END POINTS MIRACLE study Abraham WT NEJM 2002

CRT reverses LV remodeling t Sutton MG Circulation 2003

Woo G W et al Journal Int Card Electroph 2005

Analysis of the MIRACLE Study Woo G W et al J Int Card Electroph 2005 Time to first HF hospitalization Women Men

Analysis of the MIRACLE Study Woo G W et al Journal Int Card Electroph 2005 Time to first HF hospitalization or death Women Men

813 pts (26%women) CARE-HF Study

Cleland JGF NEJM 2005

1820 pts 24% women NYHA class I or II MADIT CRT

Risk of Death or Heart Failure, According to Selected Clinical Characteristics Moss AJ NEJM 2009

Linde C JACC pts NYHA class I or II

REVERSE Study Linde C JACC pts NYHA class I or II Effect of CRT on LVESVI

141 pts Yu CM Circulation 2005

Few observational studies have shown that ………….

Does a Gender Difference in Response to C RT Exist? Bleeker GB PACE 2005

Does a Gender Difference in Response to C RT Exist? Bleeker GB PACE 2005

Does a Gender Difference in Response to C RT Exist? Bleeker GB PACE 2005 Response based on improvement in NYHA class

The Impact of Age and Gender on Cardiac Resynchronization Therapy Outcome Baseline Characteristics of Patients Stratified by Gender Zardkoohi O et al PACE 2007

The Impact of Age and Gender on Cardiac Resynchronization Therapy Outcome Hospitalization for heart failure and/or death free survival curve Zardkoohi O et al PACE 2007

The Impact of Age and Gender on Cardiac Resynchronization Therapy Outcome When stratified by the etiology of the underlying cardiomyopathy, ischemic women appear to have a worse long-term outcome than all other groups Zardkoohi O et al PACE 2007

Lilli A PACE 2007 CRT: Gender Related Differences in Left Ventricular Reverse Remodeling 195pts (23%women)

Lilli A PACE 2007 CRT: Gender Related Differences in Left Ventricular Reverse Remodeling ◄ ◄

Lilli A PACE 2007 CRT: Gender Related Differences in Left Ventricular Reverse Remodeling

Lilli A PACE 2007 CRT: Gender Related Differences in Left Ventricular Reverse Remodeling

CRT Trials and observational studies show discordant results However a gender related difference in response to CRT seems to occur It is not surprising since there are many reasons why male and female hearts are not the same

Gender Differences in Advanced HF: Insights From the BEST Study Baseline Clinical Characteristics by Gender Ghali JK JACC pts(28%omen Randomized to Bucindolo or Placebo

Left ventricular Ejection Fractionin Women and Men with Congestive Heart Failure Hsich EM JACC 2009 Heart Failure in Women :A Need for Prospective Data

Myocardial Response to Pressure Overload Women Men Sex-Related Differences in Myocardial Remodeling Piro M et al JACC 2010

Echocardiographic characteristics of patients with aortic stenosis Left ventricular geometry and function in patients with aortic stenosis: gender differences Kostkiewicz M Int J Cardiol 1999

Placebo E2 van Eickels M Circulation 2001 TAC Transverse Aortic Constriction

Myocyte Death in the Failing Human Heart Is Gender Dependent Guerra S Circulation Research 1999

Jessup, M. J Thorac Cardiovasc Surg 2004 Gender-related survival rates and how they might be influenced by different pathophysiologic mechanisms in men and women. LVH, left ventricular hypertrophy; RAS, renin-angiotensin system; SNS, sympathetic nervous system.

CRT: vi è un vantaggio maggiore nelle donne? Al momento attuale la scarsa rappresentazione delle donne negli studi sulla terapia cardiaca resincronizzante fa si che ancora non vi siano chiare evidenze su un loro maggior beneficio tuttavia Le particolari caratteristiche dello scompenso cardiaco ed in particolare i diversi meccanismi che modulano il rimodellamento ventricolare nelle done rappresentano importanti presupposti per una loro migliore risposta Conclusioni